Unding, Farida .
HRN: 00-11-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/02/2023
03/08/2023
IV
500mg
OD
Respiratory Failure Prob Massive PE-intubated
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes